Clinical trial

Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction

NCT04327596

Study summary

ClinicalTrials.gov

Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

PROCEDURE · Unmapped registry intervention RF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheter Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-01-25

PhaseNA

Conditions

Heart Failure With Preserved Ejection Fractionunresolved

Interventions

RF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheterPROCEDURE

Sponsors & collaborators

University of Rochesterlead sponsor

Biosense Webster, Inc.collaborator

Mapped research locations

RochesterNew York, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04327596 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.